dostarlimab
gsk
['crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'dostarlimab']
neoadjuvant dostarlimab (anti pd-1) resulted in 100% clinical cr in 12 patients with #mmrd stage ii/iii rectal cancer. small cohort and relatively short follow up, yet looks promising . #asco22 #crcsm
Family man. Culé. Sports enthusiast. Medical #Oncologist at @rambamhcc. Save Earth, Its the only planet with chocolate.